Results
Revise Search
Antimicrobial stewardship and antimicrobial resistance surveillance
https://policybase.cma.ca/en/permalink/policy13710
- Date
- 2017-08-23
- Topics
- Health care and patient safety
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
- Resolution
- GC17-11
- The Canadian Medical Association calls on the federal government to use Canada’s term as G7 President in 2018 to add antimicrobial stewardship and antimicrobial resistance surveillance as part of their agenda.
- Policy Type
- Policy resolution
- Date
- 2017-08-23
- Resolution
- GC17-11
- The Canadian Medical Association calls on the federal government to use Canada’s term as G7 President in 2018 to add antimicrobial stewardship and antimicrobial resistance surveillance as part of their agenda.
Bill C-224, Good Samaritan Drug Overdose Act
https://policybase.cma.ca/en/permalink/policy11910
- Date
- 2016-08-24
- Topics
- Health care and patient safety
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
- Resolution
- GC16-40
- The Canadian Medical Association supports Bill C-224, Good Samaritan Drug Overdose Act.
- Policy Type
- Policy resolution
- Date
- 2016-08-24
- Resolution
- GC16-40
- The Canadian Medical Association supports Bill C-224, Good Samaritan Drug Overdose Act.
Canadian guideline for safe and effective use of opioids for chronic pain
https://policybase.cma.ca/en/permalink/policy11901
- Date
- 2016-08-24
- Topics
- Health care and patient safety
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
- Resolution
- GC16-30
- The Canadian Medical Association recommends that the Canadian Guideline for Safe and Effective Use of Opioids for Chronic Non-Cancer Pain include consideration of pharmacokinetic and pharmacodynamic factors specific to older adults.
- Policy Type
- Policy resolution
- Date
- 2016-08-24
- Resolution
- GC16-30
- The Canadian Medical Association recommends that the Canadian Guideline for Safe and Effective Use of Opioids for Chronic Non-Cancer Pain include consideration of pharmacokinetic and pharmacodynamic factors specific to older adults.
CMA’s Recommendations for Bill S-5: An Act to amend the Tobacco Act and the Non-smokers’ Health Act and to make consequential amendments to other Acts
https://policybase.cma.ca/en/permalink/policy13641
- Date
- 2017-04-07
- Topics
- Health care and patient safety
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
1 document
Consultation on the renewal of Federal Tobacco Control Strategy
https://policybase.cma.ca/en/permalink/policy13804
- Date
- 2017-04-05
- Topics
- Health care and patient safety
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
1 document
Health Canada’s Consultation on “Plain and Standardized Packaging”
https://policybase.cma.ca/en/permalink/policy13817
- Date
- 2016-08-12
- Topics
- Health care and patient safety
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
1 document
Opioid overdose prevention supplies available in publicly accessible locations
https://policybase.cma.ca/en/permalink/policy13703
- Date
- 2017-08-23
- Topics
- Health care and patient safety
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
- Resolution
- GC17-06
- The Canadian Medical Association supports making naloxone and other opioid overdose prevention supplies available in publicly accessible locations.
- Policy Type
- Policy resolution
- Date
- 2017-08-23
- Resolution
- GC17-06
- The Canadian Medical Association supports making naloxone and other opioid overdose prevention supplies available in publicly accessible locations.
Regulation of Self-Care Products in Canada
https://policybase.cma.ca/en/permalink/policy13802
- Date
- 2016-10-31
- Topics
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
- Health care and patient safety
1 document
Regulatory framework for the mandatory reporting of adverse drug reactions and medical device incidents by provincial and territorial healthcare institutions.
https://policybase.cma.ca/en/permalink/policy11814
- Date
- 2016-01-20
- Topics
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
- Health care and patient safety
1 document
Standardized non-pharmacologic order sets
https://policybase.cma.ca/en/permalink/policy11903
- Date
- 2016-08-24
- Topics
- Health care and patient safety
- Pharmaceuticals/ prescribing/ cannabis/ marijuana/ drugs
- Resolution
- GC16-32
- The Canadian Medical Association advocates for the development of national standardized non-pharmacologic order sets for the treatment of older adults with delirium.
- Policy Type
- Policy resolution
- Date
- 2016-08-24
- Resolution
- GC16-32
- The Canadian Medical Association advocates for the development of national standardized non-pharmacologic order sets for the treatment of older adults with delirium.